Séverine Vermeire

Universitair Ziekenhuis Leuven (BE)

Research Areas

Discover Papers by Séverine Vermeire

Access 250+ million papers and cite this researcher's work with AI assistance

Try AnswerThis Free →

H-index

165

Publications

2372

Citations

113485

i10-index

783

Publications & Citations Over Time

Top Cited Publications

Want to find and read papers by this researcher? AnswerThis gives you instant access.

Title	Year	Citations
Host–microbe interactions have shaped the genetic ...	2012	4905
Toward an Integrated Clinical, Molecular and Serol...	2005	3406
Genome-wide association defines more than 30 disti...	2008	2640
Genome-wide meta-analysis increases to 71 the numb...	2010	2593
Influence of Immunogenicity on the Long-Term Effic...	2003	2020
A decrease of the butyrate-producing species <i>Ro...	2013	1923
Ustekinumab as Induction and Maintenance Therapy f...	2016	1831
Tofacitinib as Induction and Maintenance Therapy f...	2017	1745
Second European evidence-based consensus on the di...	2012	1553
Meta-analysis identifies 29 additional ulcerative ...	2011	1357

Publications

1.
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
Year: 2012Citations: 4905DOI: 10.1038/nature11582
2.
Toward an Integrated Clinical, Molecular and Serological Classification of Inflammatory Bowel Disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology
Year: 2005Citations: 3406DOI: 10.1155/2005/269076
3.
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
Year: 2008Citations: 2640DOI: 10.1038/ng.175
4.
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
Year: 2010Citations: 2593DOI: 10.1038/ng.717
5.
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
Year: 2003Citations: 2020DOI: 10.1056/nejmoa020888
6.
A decrease of the butyrate-producing species <i>Roseburia hominis</i> and <i>Faecalibacterium prausnitzii</i> defines dysbiosis in patients with ulcerative colitis
Year: 2013Citations: 1923DOI: 10.1136/gutjnl-2013-304833
7.
Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
Year: 2016Citations: 1831DOI: 10.1056/nejmoa1602773
8.
Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
Year: 2017Citations: 1745DOI: 10.1056/nejmoa1606910
9.
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
Year: 2012Citations: 1553DOI: 10.1016/j.crohns.2012.09.002
10.
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47
Year: 2011Citations: 1357DOI: 10.1038/ng.764

About Séverine Vermeire

Séverine Vermeire is a researcher with 2372 publications and 113485 citations. They are affiliated with Universitair Ziekenhuis Leuven. Their research focuses on . With an h-index of 165, they are among the top researchers in their field.

Citation Distribution

Distribution of citations across publications

Research Smarter

AnswerThis uses AI to help you search, understand, and cite research from Séverine Vermeire and 250M+ other papers.

AI-powered research assistance
Automatic citations and references
Advanced academic writing tools

Research Area Breakdown

Publication Types

Publication type data not available

Impact Metrics Over Time

Citations per publication by year